Overview
Johannes Lubke practices in Mannheim, Germany. Mr. Lubke is rated as an Elite expert by MediFind in the treatment of Systemic Mastocytosis. His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Leukocytosis, and Hypereosinophilic Syndrome.
His clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles in the study of Systemic Mastocytosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mast Cell Activation Syndrome (MCAS)
- Systemic MastocytosisMr. Lubke isElite. Learn about Systemic Mastocytosis.
- Advanced
- LeukocytosisMr. Lubke isAdvanced. Learn about Leukocytosis.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Lubke isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMr. Lubke isExperienced. Learn about Agranulocytosis.
- Hypereosinophilic SyndromeMr. Lubke isExperienced. Learn about Hypereosinophilic Syndrome.
- LeukemiaMr. Lubke isExperienced. Learn about Leukemia.
- Lymphofollicular HyperplasiaMr. Lubke isExperienced. Learn about Lymphofollicular Hyperplasia.